{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:26:11Z","timestamp":1785522371609,"version":"3.56.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ongoing Research Funding Project, King Saud University","award":["ORF-2026-84"],"award-info":[{"award-number":["ORF-2026-84"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53427-1","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:23:32Z","timestamp":1779434612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Esculeoside A attenuates aortic remodeling and early atherosclerosis-like changes, with protective effects strongly associated with Nrf2 activation in high-cholesterol-fed rats"],"prefix":"10.1038","volume":"16","author":[{"given":"Talal Abdulaziz","family":"Alfurayh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu ElGasim A.","family":"Yagoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghedeir M.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajapandiyan","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal A.","family":"Albadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Naif","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abdo","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"53427_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53427_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063346","volume":"23","author":"S Jebari-Benslaiman","year":"2022","unstructured":"Jebari-Benslaiman, S. et al. Pathophysiology of atherosclerosis. Int. J. Mol. Sci. 23, 3346 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"53427_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong, P. et al. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduct. Target. Ther. 7, 131 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"53427_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady, A. et al. Inflammation in atherosclerosis: Pathophysiology and mechanisms. Cell Death Dis. 15, 817 (2024).","journal-title":"Cell Death Dis."},{"key":"53427_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.707529","volume":"8","author":"K Malekmohammad","year":"2021","unstructured":"Malekmohammad, K., Bezsonov, E. E. & Rafieian-Kopaei, M. Role of lipid accumulation and inflammation in atherosclerosis: Focus on molecular and cellular mechanisms. Front. Cardiovasc. Med. 8, 707529 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"53427_CR6","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2017044","volume":"58","author":"A Phrommintikul","year":"2017","unstructured":"Phrommintikul, A. et al. Management of atherosclerosis risk factors for patients at high cardiovascular risk in real-world practice: A multicentre study. Singapore Med. J. 58, 535 (2017).","journal-title":"Singapore Med. J."},{"key":"53427_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00600","volume":"8","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. Oxidative stress-mediated atherosclerosis: Mechanisms and therapies. Front. Physiol. 8, 600 (2017).","journal-title":"Front. Physiol."},{"key":"53427_CR8","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.3390\/cells11233843","volume":"11","author":"M Batty","year":"2022","unstructured":"Batty, M., Bennett, M. R. & Yu, E. The role of oxidative stress in atherosclerosis. Cells 11, 3843 (2022).","journal-title":"Cells"},{"key":"53427_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak, A. et al. The diabetes mellitus\u2013atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 21, 1835 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"53427_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biom9080301","volume":"9","author":"K Malekmohammad","year":"2019","unstructured":"Malekmohammad, K., Sewell, R. D. & Rafieian-Kopaei, M. Antioxidants and atherosclerosis: Mechanistic aspects. Biomolecules 9, 301 (2019).","journal-title":"Biomolecules"},{"key":"53427_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04361-7","volume":"21","author":"Q Yan","year":"2023","unstructured":"Yan, Q. et al. Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease. J. Transl. Med. 21, 519 (2023).","journal-title":"J. Transl. Med."},{"key":"53427_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9237263","volume":"2017","author":"S Satta","year":"2017","unstructured":"Satta, S., Mahmoud, A. M., Wilkinson, F. L., Alexander, Y. M. & White, S. J. The role of Nrf2 in cardiovascular function and disease. Oxid. Med. Cell. Longev. 2017, 9237263 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"53427_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112336","volume":"18","author":"BK Ooi","year":"2017","unstructured":"Ooi, B. K., Goh, B. H. & Yap, W. H. Oxidative stress in cardiovascular diseases: Involvement of Nrf2 antioxidant redox signaling in macrophage foam cells formation. Int. J. Mol. Sci. 18, 2336 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"53427_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","volume":"59","author":"M Dodson","year":"2019","unstructured":"Dodson, M. et al. Modulating NRF2 in disease: Timing is everything. Annu. Rev. Pharmacol. Toxicol. 59, 555\u2013575 (2019).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"53427_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166714","volume":"1869","author":"M Hashemi","year":"2023","unstructured":"Hashemi, M. et al. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective. Biochim. Biophys. Acta (BBA) 1869, 166714 (2023).","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"53427_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100973","volume":"9","author":"LT Suraweera","year":"2020","unstructured":"Suraweera, L. T., Rupasinghe, H. V., Dellaire, G. & Xu, Z. Regulation of Nrf2\/ARE pathway by dietary flavonoids: A friend or foe for cancer management?. Antioxidants 9, 973 (2020).","journal-title":"Antioxidants"},{"key":"53427_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.14336\/AD.2018.0513","volume":"10","author":"W Tu","year":"2019","unstructured":"Tu, W., Wang, H., Li, S., Liu, Q. & Sha, H. The anti-inflammatory and anti-oxidant mechanisms of the Keap1\/Nrf2\/ARE signaling pathway in chronic diseases. Aging Dis. 10, 637 (2019).","journal-title":"Aging Dis."},{"key":"53427_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/antiox10091463","volume":"10","author":"JA Alonso-Pi\u00f1eiro","year":"2021","unstructured":"Alonso-Pi\u00f1eiro, J. A., Gonzalez-Rovira, A., S\u00e1nchez-Gomar, I., Moreno, J. A. & Dur\u00e1n-Ruiz, M. C. Nrf2 and heme oxygenase-1 involvement in atherosclerosis related oxidative stress. Antioxidants 10, 1463 (2021).","journal-title":"Antioxidants"},{"key":"53427_CR19","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha, S., Buttari, B., Panieri, E., Profumo, E. & Saso, L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25, 5474 (2020).","journal-title":"Molecules"},{"key":"53427_CR20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/ATVBAHA.109.193375","volume":"29","author":"M Zakkar","year":"2009","unstructured":"Zakkar, M. et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler. Thromb. Vasc. Biol. 29, 1851\u20131857 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53427_CR21","doi-asserted-by":"publisher","first-page":"H18","DOI":"10.1152\/ajpheart.00260.2010","volume":"299","author":"Z Ungvari","year":"2010","unstructured":"Ungvari, Z. et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am. J. Physiol. Heart Circ. Physiol. 299, H18\u2013H24 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"53427_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1515\/jbcpp-2014-0057","volume":"26","author":"M Jayachandran","year":"2015","unstructured":"Jayachandran, M., Chandrasekaran, B. & Namasivayam, N. Geraniol attenuates oxidative stress by Nrf2 activation in diet-induced experimental atherosclerosis. J. Basic Clin. Physiol. Pharmacol. 26, 335\u2013346 (2015).","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"53427_CR23","first-page":"3860","volume":"28","author":"K Tao","year":"2017","unstructured":"Tao, K., Chen, J. & Wang, L. Effects of berberine on the expressions of NRF2 and HO-1 in endothelial cells of diabetic rat. Biomed. Res. 28, 3860\u20133864 (2017).","journal-title":"Biomed. Res."},{"key":"53427_CR24","volume":"11","author":"H Jia","year":"2018","unstructured":"Jia, H. et al. Fibroblast growth factor 21 attenuates inflammation and oxidative stress in atherosclerotic rat via enhancing the Nrf1-ARE signaling pathway. Int. J. Clin. Exp. Pathol. 11, 1308 (2018).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"53427_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2019.02.010","volume":"284","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. Z-Ligustilide protects vascular endothelial cells from oxidative stress and rescues high fat diet-induced atherosclerosis by activating multiple NRF2 downstream genes. Atherosclerosis 284, 110\u2013120 (2019).","journal-title":"Atherosclerosis"},{"key":"53427_CR26","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202829","volume":"13","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells. Aging (Albany NY) 13, 11363 (2021).","journal-title":"Aging (Albany NY)"},{"key":"53427_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","volume":"34","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Activation of Nrf2\/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J. Adv. Res. 34, 43\u201363 (2021).","journal-title":"J. Adv. Res."},{"key":"53427_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/toxres\/tfac070","volume":"11","author":"N Aslam","year":"2022","unstructured":"Aslam, N., Faisal, M. N., Khan, J. A. & Majeed, W. Opuntia ficus indica (L.) fruit extract alleviates oxidative stress through activation of dual oxidases and Keap1\/Nrf2 signaling cascades in high-fat-diet associated atherosclerosis rats. Toxicol. Res. 11, 920\u2013930 (2022).","journal-title":"Toxicol. Res."},{"key":"53427_CR29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10787-023-01161-9","volume":"31","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice. Inflammopharmacology 31, 1993\u20132005 (2023).","journal-title":"Inflammopharmacology"},{"key":"53427_CR30","doi-asserted-by":"crossref","unstructured":"Song, J. et al. Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice. J. Clin. Investig. 134. (2024).","DOI":"10.1172\/JCI173034"},{"key":"53427_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103229","volume":"74","author":"L He","year":"2024","unstructured":"He, L. et al. Activation of Nrf2 inhibits atherosclerosis in ApoE\u2212\/\u2212 mice through suppressing endothelial cell inflammation and lipid peroxidation. Redox Biol. 74, 103229 (2024).","journal-title":"Redox Biol."},{"key":"53427_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/jcmm.16106","volume":"25","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in ApoE(-\/-) mice. J. Cell. Mol. Med. 25, 521\u2013534. https:\/\/doi.org\/10.1111\/jcmm.16106 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"53427_CR33","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1096\/fj.201802251R","volume":"33","author":"L Gu","year":"2019","unstructured":"Gu, L. et al. Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE(-\/-) mice by up-regulating heme oxygenase-1 via PI3K\/Akt\/Nrf2\/ARE pathway. FASEB J. 33, 4836\u20134850. https:\/\/doi.org\/10.1096\/fj.201802251R (2019).","journal-title":"FASEB J."},{"key":"53427_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/fjc.0000000000000769","volume":"75","author":"XJ Yang","year":"2020","unstructured":"Yang, X. J. et al. Berberine attenuates cholesterol accumulation in macrophage foam cells by suppressing AP-1 activity and activation of the Nrf2\/HO-1 pathway. J. Cardiovasc. Pharmacol. 75, 45\u201353. https:\/\/doi.org\/10.1097\/fjc.0000000000000769 (2020).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"53427_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050950","author":"T Wolak","year":"2019","unstructured":"Wolak, T. et al. Effect of Tomato Nutrient Complex on blood pressure: A double blind, randomized dose\u207bresponse study. Nutrients https:\/\/doi.org\/10.3390\/nu11050950 (2019).","journal-title":"Nutrients"},{"key":"53427_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/circresaha.118.313348","volume":"124","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez, M. A., Gea, A. & Ruiz-Canela, M. The Mediterranean diet and cardiovascular health. Circ. Res. 124, 779\u2013798. https:\/\/doi.org\/10.1161\/circresaha.118.313348 (2019).","journal-title":"Circ. Res."},{"key":"53427_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.849841","volume":"9","author":"M C\u00e1mara","year":"2022","unstructured":"C\u00e1mara, M. et al. Scientific evidence of the beneficial effects of tomato products on cardiovascular disease and platelet aggregation. Front. Nutr. 9, 849841. https:\/\/doi.org\/10.3389\/fnut.2022.849841 (2022).","journal-title":"Front. Nutr."},{"key":"53427_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.01.009","volume":"257","author":"HM Cheng","year":"2017","unstructured":"Cheng, H. M. et al. Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis. Atherosclerosis 257, 100\u2013108. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.009 (2017).","journal-title":"Atherosclerosis"},{"key":"53427_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020239","author":"EJ Collins","year":"2022","unstructured":"Collins, E. J., Bowyer, C., Tsouza, A. & Chopra, M. Tomatoes: An extensive review of the associated health impacts of tomatoes and factors that can affect their cultivation. Biology https:\/\/doi.org\/10.3390\/biology11020239 (2022).","journal-title":"Biology"},{"key":"53427_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2543-3","volume":"19","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. Hypoglycemic effects of esculeoside A are mediated via activation of AMPK and upregulation of IRS-1. BMC Complement. Altern. Med. 19, 136. https:\/\/doi.org\/10.1186\/s12906-019-2543-3 (2019).","journal-title":"BMC Complement. Altern. Med."},{"key":"53427_CR41","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1161\/atvbaha.107.147405","volume":"27","author":"Y Fujiwara","year":"2007","unstructured":"Fujiwara, Y. et al. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT. Arterioscler. Thromb. Vasc. Biol. 27, 2400\u20132406. https:\/\/doi.org\/10.1161\/atvbaha.107.147405 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53427_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101830","author":"AL Jz","year":"2023","unstructured":"Jz, A. L. et al. Esculeoside A decreases diabetic cardiomyopathy in Streptozotocin-treated rats by attenuating oxidative stress, inflammation, fibrosis, and apoptosis: Impressive role of Nrf2. Medicina (Kaunas) https:\/\/doi.org\/10.3390\/medicina59101830 (2023).","journal-title":"Medicina (Kaunas)"},{"key":"53427_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116461","volume":"173","author":"NA Alsabaani","year":"2024","unstructured":"Alsabaani, N. A. et al. Nrf2-dependent antioxidant and anti-inflammatory effects underlie the protective effect of esculeoside A against retinal damage in streptozotocin-induced diabetic rats. Biomed. Pharmacother. 173, 116461. https:\/\/doi.org\/10.1016\/j.biopha.2024.116461 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"53427_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/01.Atv.0000201071.49029.17","volume":"26","author":"GS Getz","year":"2006","unstructured":"Getz, G. S. & Reardon, C. A. Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 242\u2013249. https:\/\/doi.org\/10.1161\/01.Atv.0000201071.49029.17 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53427_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143979","volume":"10","author":"M Nozako","year":"2015","unstructured":"Nozako, M. et al. An atherogenic Paigen-diet aggravates nephropathy in Type 2 diabetic OLETF rats. PLoS One 10, e0143979. https:\/\/doi.org\/10.1371\/journal.pone.0143979 (2015).","journal-title":"PLoS One"},{"key":"53427_CR46","doi-asserted-by":"publisher","DOI":"10.4174\/jkss.2011.80.2.131","volume":"80","author":"S Kim","year":"2011","unstructured":"Kim, S., Hwang, J., Park, S.-C., Kim, J. & Moon, I. Relationship of serum ferritin, cholesterol, and intimal hyperplasia after mechanical injury to carotid artery in a rat model. J. Korean Surg. Soc. 80, 131. https:\/\/doi.org\/10.4174\/jkss.2011.80.2.131 (2011).","journal-title":"J. Korean Surg. Soc."},{"key":"53427_CR47","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3892\/etm.2013.1333","volume":"6","author":"H Yang","year":"2013","unstructured":"Yang, H., Hwang, I., Kim, S., Hong, E. J. & Jeung, E. B. Lentinus edodes promotes fat removal in hypercholesterolemic mice. Exp. Ther. Med. 6, 1409\u20131413. https:\/\/doi.org\/10.3892\/etm.2013.1333 (2013).","journal-title":"Exp. Ther. Med."},{"key":"53427_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3468040","volume":"2018","author":"HJ Baek","year":"2018","unstructured":"Baek, H. J. et al. Antihyperglycemic and antilipidemic effects of the ethanol extract mixture of Ligularia fischeri and Momordica charantia in Type II diabetes-mimicking mice. Evid. Based Complement. Alternat. Med. 2018, 3468040. https:\/\/doi.org\/10.1155\/2018\/3468040 (2018).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"53427_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nutres.2019.01.001","volume":"64","author":"MJ Jeong","year":"2019","unstructured":"Jeong, M. J., Kim, S. R. & Jung, U. J. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Nutr. Res. 64, 64\u201371. https:\/\/doi.org\/10.1016\/j.nutres.2019.01.001 (2019).","journal-title":"Nutr. Res."},{"key":"53427_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12100609","author":"GH Kang","year":"2020","unstructured":"Kang, G. H. et al. Bee venom phospholipase A2 ameliorates atherosclerosis by modulating regulatory T cells. Toxins (Basel) https:\/\/doi.org\/10.3390\/toxins12100609 (2020).","journal-title":"Toxins (Basel)"},{"issue":"22","key":"53427_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu15224755","volume":"15","author":"JM Al Jadani","year":"2023","unstructured":"Al Jadani, J. M. et al. Esculeogenin A, a glycan from tomato, alleviates nonalcoholic fatty liver disease in rats through hypolipidemic, antioxidant, and anti-inflammatory effects. Nutrients 15(22), 4755. https:\/\/doi.org\/10.3390\/nu15224755 (2023).","journal-title":"Nutrients"},{"key":"53427_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/nu1611169953","volume":"16","author":"JR Zhou","year":"2024","unstructured":"Zhou, J. R. et al. Saponin Esculeoside A and aglycon Esculeogenin A from ripe tomatoes inhibit dendritic cell function by attenuation of Toll-like receptor 4 signaling. Nutrients 16, 1699. https:\/\/doi.org\/10.3390\/nu1611169953 (2024).","journal-title":"Nutrients"},{"issue":"4","key":"53427_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MOL.0000000000000938","volume":"35","author":"LR Brunham","year":"2024","unstructured":"Brunham, L. R. Familial hypercholesterolemia-Plus: Is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?. Curr. Opin. Lipidol. 35(4), 219\u2013221. https:\/\/doi.org\/10.1097\/MOL.0000000000000938 (2024).","journal-title":"Curr. Opin. Lipidol."},{"key":"53427_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajpath.2022.09.004","volume":"193","author":"L Mastrogiacomo","year":"2023","unstructured":"Mastrogiacomo, L. et al. The effects of hyperglycemia on early endothelial activation and the initiation of atherosclerosis. Am. J. Pathol. 193, 121\u2013133. https:\/\/doi.org\/10.1016\/j.ajpath.2022.09.004 (2023).","journal-title":"Am. J. Pathol."},{"key":"53427_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson, D. & Rayfield, E. J. How hyperglycemia promotes atherosclerosis: Molecular mechanisms. Cardiovasc. Diabetol. 1, 1. https:\/\/doi.org\/10.1186\/1475-2840-1-1 (2002).","journal-title":"Cardiovasc. Diabetol."},{"key":"53427_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/569654","volume":"2012","author":"SD Funk","year":"2012","unstructured":"Funk, S. D., Yurdagul, A. Jr. & Orr, A. W. Hyperglycemia and endothelial dysfunction in atherosclerosis: Lessons from type 1 diabetes. Int. J. Vasc. Med. 2012, 569654. https:\/\/doi.org\/10.1155\/2012\/569654 (2012).","journal-title":"Int. J. Vasc. Med."},{"key":"53427_CR57","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/circresaha.120.316653","volume":"127","author":"MC Flynn","year":"2020","unstructured":"Flynn, M. C. et al. Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circ. Res. 127, 877\u2013892. https:\/\/doi.org\/10.1161\/circresaha.120.316653 (2020).","journal-title":"Circ. Res."},{"key":"53427_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0026-0495(88)90180-1","volume":"37","author":"MW Stolar","year":"1988","unstructured":"Stolar, M. W. Atherosclerosis in diabetes: The role of hyperinsulinemia. Metabolism 37, 1\u20139. https:\/\/doi.org\/10.1016\/0026-0495(88)90180-1 (1988).","journal-title":"Metabolism"},{"key":"53427_CR59","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/er.2018-00141","volume":"40","author":"A Di Pino","year":"2019","unstructured":"Di Pino, A. & DeFronzo, R. A. Insulin resistance and atherosclerosis: Implications for insulin-sensitizing agents. Endocr. Rev. 40, 1447\u20131467. https:\/\/doi.org\/10.1210\/er.2018-00141 (2019).","journal-title":"Endocr. Rev."},{"key":"53427_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.06.016","volume":"307","author":"S Chandel","year":"2020","unstructured":"Chandel, S. et al. Hyperinsulinemia promotes endothelial inflammation via increased expression and release of Angiopoietin-2. Atherosclerosis 307, 1\u201310. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.06.016 (2020).","journal-title":"Atherosclerosis"},{"key":"53427_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102416","author":"S Fazio","year":"2024","unstructured":"Fazio, S., Bellavite, P. & Affuso, F. Chronically increased levels of circulating insulin secondary to insulin resistance: A silent killer. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines12102416 (2024).","journal-title":"Biomedicines"},{"key":"53427_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/nu15224755","author":"JM Al Jadani","year":"2023","unstructured":"Al Jadani, J. M. et al. Esculeogenin A, a glycan from tomato, alleviates nonalcoholic fatty liver disease in rats through hypolipidemic, antioxidant, and anti-inflammatory effects. Nutrients https:\/\/doi.org\/10.3390\/nu15224755 (2023).","journal-title":"Nutrients"},{"key":"53427_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097910","author":"E Gusev","year":"2023","unstructured":"Gusev, E. & Sarapultsev, A. Atherosclerosis and inflammation: Insights from the theory of general pathological processes. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24097910 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"53427_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady, A. et al. Inflammation in atherosclerosis: Pathophysiology and mechanisms. Cell Death Dis. 15, 817. https:\/\/doi.org\/10.1038\/s41419-024-07166-8 (2024).","journal-title":"Cell Death Dis."},{"key":"53427_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2015.06.019","volume":"88","author":"J Mimura","year":"2015","unstructured":"Mimura, J. & Itoh, K. Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic. Biol. Med. 88, 221\u2013232. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.06.019 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"53427_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1057918","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X., Wei, J., Yi, Y., Gong, Q. & Gao, J. Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products. Front. Pharmacol. 13, 1057918. https:\/\/doi.org\/10.3389\/fphar.2022.1057918 (2022).","journal-title":"Front. Pharmacol."},{"key":"53427_CR67","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.4049\/jimmunol.161.6.2873","volume":"161","author":"SK Manna","year":"1998","unstructured":"Manna, S. K. & Aggarwal, B. B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161, 2873\u20132880 (1998).","journal-title":"J. Immunol."},{"key":"53427_CR68","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.1021\/jf102812t","volume":"58","author":"P-C Liao","year":"2010","unstructured":"Liao, P.-C. et al. Osthole regulates inflammatory mediator expression through modulating NF-\u03baB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species. J. Agric. Food Chem. 58, 10445\u201310451 (2010).","journal-title":"J. Agric. Food Chem."},{"key":"53427_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ddstr.2008.02.001","volume":"5","author":"JA Leopold","year":"2008","unstructured":"Leopold, J. A. & Loscalzo, J. Oxidative mechanisms and atherothrombotic cardiovascular disease. Drug Discov. Today Ther. Strateg. 5, 5\u201313 (2008).","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"53427_CR70","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/jf204197r","volume":"60","author":"Y Fujiwara","year":"2012","unstructured":"Fujiwara, Y. et al. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA: cholesterol acyl-transferase (ACAT). J. Agric. Food Chem. 60, 2472\u20132479 (2012).","journal-title":"J. Agric. Food Chem."},{"key":"53427_CR71","doi-asserted-by":"publisher","first-page":"G1211","DOI":"10.1152\/ajpgi.00322.2010","volume":"299","author":"J Huang","year":"2010","unstructured":"Huang, J., Tabbi-Anneni, I., Gunda, V. & Wang, L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1211\u2013G1221 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"53427_CR72","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/1873-3468.14993","volume":"598","author":"A Luchkova","year":"2024","unstructured":"Luchkova, A., Mata, A. & Cadenas, S. Nrf2 as a regulator of energy metabolism and mitochondrial function. FEBS Lett. 598, 2092\u20132105 (2024).","journal-title":"FEBS Lett."},{"issue":"5","key":"53427_CR73","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41419-022-04923-5","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M. et al. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 13467. (2022).","journal-title":"Cell Death Dis."},{"key":"53427_CR74","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0008-6363(99)00235-7","volume":"45","author":"MM Kockx","year":"2000","unstructured":"Kockx, M. M. & Herman, A. G. Apoptosis in atherosclerosis: Beneficial or detrimental?. Cardiovasc. Res. 45, 736\u2013746 (2000).","journal-title":"Cardiovasc. Res."},{"key":"53427_CR75","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/CS20040086","volume":"107","author":"VE Stoneman","year":"2004","unstructured":"Stoneman, V. E. & Bennett, M. R. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond.) 107, 343\u2013354 (2004).","journal-title":"Clin. Sci. (Lond.)"},{"key":"53427_CR76","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/ATVBAHA.111.224873","volume":"32","author":"EA Van Vr\u00e9","year":"2012","unstructured":"Van Vr\u00e9, E. A., Ait-Oufella, H., Tedgui, A. & Mallat, Z. Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 887\u2013893 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53427_CR77","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1074\/jbc.RA120.013093","volume":"295","author":"WP Miller","year":"2020","unstructured":"Miller, W. P. et al. The stress response protein REDD1 promotes diabetes-induced oxidative stress in the retina by Keap1-independent Nrf2 degradation. J. Biol. Chem. 295, 7350\u20137361 (2020).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53427-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:14:35Z","timestamp":1785518075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53427-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53427-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols conducted on these animals were approved by the Research Ethics Committee, King Saud University, Riyadh, Saudi Arabia (Ethics Reference No: KSU-SE-25-13). The authors confirm that all methods were performed in accordance with the full ARRIVE guidelines (\n                      \n                      ). Furthermore, the study followed the US National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals (NIH publication no. 85\u2009\u2212\u200923, revised 1996) and strictly adhered to the ethical guidelines and regulations stipulated by the Research Ethics Committee.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23370"}}